We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Ovary Transplanted to Arm Preserves Fertility

By HospiMedica staff writers
Posted on 16 Nov 2004
Transplanting an ovary to the upper arm is feasible and preserves hormonal function in women undergoing treatment for cervical cancer, according to a study published in the November 8, 2004, online edition of Cancer.

Although chemotherapy and radiation improve survival and cure rates for women with cervical cancer, such treatments can also cause permanent ovarian failure and infertility during a woman's reproductive years. More...
Cryopreservation of embryos has been successful but there has been no successful cryopreservation or transplantation of oocytes or primordial follicles, necessary for future fertility.

In this second human trial, C. Hilders, M.D., Ph.D., and a gynecologic surgical team at Leiden University Hospital (The Netherlands) developed a new method of autotransplantation to preserve ovarian function in women treated for cervical cancer. This method does not require developing a donor site with an implant over several months, and utilizes a donor site that is easily accessible to noninvasive monitoring and has suitable vasculature.

The team autotransplanted a healthy ovary into the upper arm of a patient, using brachial vessels to establish blood supply, which resulted in a functional ovary. Blood to and from the ovary was adequate to maintain cyclical follicular growth as verified by ultrasound and clinical examination. Moreover, the surgery did not result in additional operating time.

"It seems likely that ovarian autotransplantation will be a realistic goal to achieve for a woman facing cancer, treated by high-dose pelvic radiation, to preserve reproductive and hormonal function, thereby substantially improving the quality of life post-treatment,” concluded the authors.




Related Links:
Leiden U. Hospital

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.